Ekso Bionics Holdings Inc (EKSO)

[Rhetorical]

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO)‘s stock had its “buy” rating restated by analysts at B. Riley in a report released on Tuesday. They currently have a $8.00 target price on the stock. B. Riley’s price target would suggest a potential upside of 92.77% from the company’s current price.

EKSO has been the subject of several other research reports. SunTrust Banks Inc. assumed coverage on shares of Ekso Bionics Holdings in a research note on Thursday, October 13th. They set a “buy” rating and a $8.00 target price for the company. Zacks Investment Research upgraded shares of Ekso Bionics Holdings from a “sell” rating to a “hold” rating in a research note on Thursday, August 11th. Finally, Rodman & Renshaw reiterated a “buy” rating on shares of Ekso Bionics Holdings in a research note on Sunday, July 31st.

Ekso Bionics Holdings (NASDAQ:EKSO) traded up 1.22% during midday trading on Tuesday, reaching $4.15. The company’s stock had a trading volume of 81,997 shares. The firm’s market capitalization is $90.80 million. The company’s 50-day moving average is $4.89 and its 200 day moving average is $5.09. Ekso Bionics Holdings has a 52 week low of $3.45 and a 52 week high of $9.80.

11/19/ekso-bionics-holdings-ekso-buy-rating-reiterated-at-b-riley.html

A number of large investors have recently made changes to their positions in the stock. KCG Holdings Inc. purchased a new stake in shares of Ekso Bionics Holdings during the third quarter worth approximately $186,000. Spark Investment Management LLC purchased a new stake in shares of Ekso Bionics Holdings during the third quarter worth approximately $185,000. Finally, Northern Trust Corp purchased a new stake in shares of Ekso Bionics Holdings during the third quarter worth approximately $130,000.

http://dailyquint.com/2016-11-21-ekso-bionics-holdings-ekso-buy-rating-reiterated-at-b-riley/

---

I'm long EKSO